compound 17b [PMID: 19639995] [Ligand Id: 14146] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL564392 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| FPR1/Formyl peptide receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3359] [GtoPdb: 222] [UniProtKB: P21462] | ||||||||
| ChEMBL | Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assay | F | 5.49 | pEC50 | 3200 | nM | EC50 | J Med Chem (2009) 52: 5044-5057 [PMID:19639995] |
| ChEMBL | Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assay | F | 6.1 | pEC50 | 800 | nM | EC50 | J Med Chem (2009) 52: 5044-5057 [PMID:19639995] |
| ChEMBL | Agonist activity at FPR1 in human neutrophiles by chemotaxis assay | F | 6.1 | pEC50 | 800 | nM | EC50 | J Med Chem (2009) 52: 5044-5057 [PMID:19639995] |
| GtoPdb | Potency for intracellular calcium mobilization | - | 6.1 | pEC50 | 800 | nM | EC50 |
Eur J Med Chem (2024) 265: 115989 [PMID:38199163]; J Med Chem (2009) 52: 5044-57 [PMID:19639995] |
| FPR2/Lipoxin A4 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4227] [GtoPdb: 223] [UniProtKB: P25090] | ||||||||
| ChEMBL | Agonist activity at FPRL1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assay | F | 6.22 | pEC50 | 600 | nM | EC50 | J Med Chem (2009) 52: 5044-5057 [PMID:19639995] |
| ChEMBL | Agonist activity at FPRL1 in human neutrophiles by chemotaxis assay | F | 6.22 | pEC50 | 600 | nM | EC50 | J Med Chem (2009) 52: 5044-5057 [PMID:19639995] |
ChEMBL data shown on this page come from version 35:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
